This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
This article was the subject of a Wiki Education Foundation-supported course assignment, between 1 September 2021 and 15 December 2021. Further details are available on the course page. Student editor(s): MBhuttor.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT ( talk) 12:13, 17 January 2022 (UTC)
I was a bit surprised to see there's no information about the general transition rates from Phase I/II, Phase II/III, III/approved, and then approved/phase IV trials.
Like, for every 1000 vaccines/drugs in phase 1 trial, how many go on to phase 2? In phase 2, how many go on to phase 3? etc.
A quick google search came up with nothing, so I figured I'd ask around here since you would know where to find that information. Interest in the article will be high during the pandemic, and I feel that's something many will wonder about. Headbomb { t · c · p · b} 21:26, 26 May 2020 (UTC)
Anyone have thoughts about using some of the data in this source for success rates? https://www.acsh.org/news/2020/06/11/clinical-trial-success-rates-phase-and-therapeutic-area-14845 It looks to cover 15 years worth of trial data. Jiltedsquirrel ( talk) 04:43, 12 December 2022 (UTC)
This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
This article was the subject of a Wiki Education Foundation-supported course assignment, between 1 September 2021 and 15 December 2021. Further details are available on the course page. Student editor(s): MBhuttor.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT ( talk) 12:13, 17 January 2022 (UTC)
I was a bit surprised to see there's no information about the general transition rates from Phase I/II, Phase II/III, III/approved, and then approved/phase IV trials.
Like, for every 1000 vaccines/drugs in phase 1 trial, how many go on to phase 2? In phase 2, how many go on to phase 3? etc.
A quick google search came up with nothing, so I figured I'd ask around here since you would know where to find that information. Interest in the article will be high during the pandemic, and I feel that's something many will wonder about. Headbomb { t · c · p · b} 21:26, 26 May 2020 (UTC)
Anyone have thoughts about using some of the data in this source for success rates? https://www.acsh.org/news/2020/06/11/clinical-trial-success-rates-phase-and-therapeutic-area-14845 It looks to cover 15 years worth of trial data. Jiltedsquirrel ( talk) 04:43, 12 December 2022 (UTC)